FDA Approves Pomalidomide (Pomalyst) for Multiple Myeloma

The US Food and Drug Administration (FDA) approved pomalidomide (Pomalyst) last week to treat patients with relapsed or refractory multiple myeloma.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news